Dr. Reddy’s signs license deal for anti-BCMA CAR-T PRG1801 in India
Besides acquiring the exclusive rights to commercialise PRG1801 in India, Dr. Reddy’s will be responsible for future development including clinical trials, in the country. Pregene will be the sole supplier